In order to realize the nanotheranostics and reduce the toxicity of nanotheranostics agents to healthy tissues/organs, we constructed a novel nanotheranostics agents (Gd-DTPA-CS@β-CD@Dox) for MR imaging and Cancer treatment. Renal-clearable nanocomposites made it possible to overcome the long-term toxicity by accumulation in healthy living body. High uptake of the as-synthesized Gd-DTPA-CS@β-CD@Dox was achieved due to the longer blood circulation time. Moreover, the nanotheranostics agents possessed excellent performance in MRI. The nanotheranostics agents demonstrated a PH sensitive drug release. Such functional nanotheranostics agents applicable in highly integrated bio-modal imaging and multiple therapeutic functions may have great prospects in clinical practice.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords